Skip to content
Screener

uniQure QURE Total Current Liabilities

Total Current Liabilities at other companies

Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$502.91M-45.3%
Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
$20.1M-10.9%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$923.6M+55.1%
Design Therapeutics, Inc. logo
Design Therapeutics, Inc.DSGN
$10.19M+23.7%
Candel Therapeutics, Inc. logo
Candel Therapeutics, Inc.CADL
$7.05M-64.9%
Regenxbio logo
RegenxbioRGNX
$82.62M-30.9%

Other financials

Income statement

See full
Revenue$5.8M+11.0%
Gross profit$5.5M+19.2%
Operating income-$52.2M-19.0%
Net income-$81.1M-115%
EPS (diluted)-$1.22-76.8%

Balance sheet

See full
Cash & equivalents$413.0M+62.8%
Total debt$62.8M-5.8%
Total equity$324.1M+8,195%
Total assets$985.1M+68.4%

Cash flow

See full
Operating cash flow-$28.6M+28.4%
CapEx$472.0K+81.5%
Free cash flow-$29.0M+27.7%

Valuation

See full
Market cap$3.15B+325%
Enterprise value$2.8B+406%
P/S168.5×+117×

Profitability

See full
Gross margin92.5%+4.6pp
Operating margin-1,071.5%-90.6pp
Net margin-1,350.7%-35.3pp
FCF margin-864.7%-194pp

Returns & leverage

See full
Return on equity-228.2%-11.6pp
Debt / equity0.2×
Current ratio10×0.0×

Where this comes from

Reported directly by uniQure in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.

The source filing: uniQure’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 7:17 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001104659-26-087815
Line itemJune 30, 2026December 31, 2025
Accrued expenses and other current liabilities51,13341,292
Liability related to pre-funded warrants24,24212,595
Current portion of operating lease liabilities2,9913,862
Total current liabilities83,34562,919
Non-current liabilities
Long-term debt50,14749,699
Liability from royalty financing agreement489,333473,199
Operating lease liabilities, net of current portion9,6969,832

Item 1.Financial Statements

FAQ

What is uniQure's total current liabilities?
uniQure (QURE) reported total current liabilities of $83.35M in Q2 2026.
How has uniQure's total current liabilities changed year-over-year?
uniQure's total current liabilities increased by 103.6% year-over-year, from $40.93M to $83.35M.
What is the long-term trend for uniQure's total current liabilities?
Over 5 years (2020 to 2025), uniQure's total current liabilities has grown at a 18.1% compound annual growth rate (CAGR), from $27.33M to $62.92M.
What does total current liabilities mean?
The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.

Ask your AI about uniQure's total current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude